Karyopharm Therapeutics Inc. Annual Return On Assets in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Karyopharm Therapeutics Inc. quarterly/annual Return On Assets history and growth rate from 2014 to 2023.
  • Karyopharm Therapeutics Inc. Return On Assets for the quarter ending September 30, 2024 was -41.3 %, a 7.66% increase year-over-year.
  • Karyopharm Therapeutics Inc. annual Return On Assets for 2023 was -50.5 %, a 13% increase from 2022.
  • Karyopharm Therapeutics Inc. annual Return On Assets for 2022 was -58 %, a 31% decline from 2021.
  • Karyopharm Therapeutics Inc. annual Return On Assets for 2021 was -44.3 %, a 18.4% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -50.5 +7.53 +13% Jan 1, 2023 Dec 31, 2023
2022 -58 -13.7 -31% Jan 1, 2022 Dec 31, 2022
2021 -44.3 +9.98 +18.4% Jan 1, 2021 Dec 31, 2021
2020 -54.3 +17.1 +24% Jan 1, 2020 Dec 31, 2020
2019 -71.4 +2.61 +3.53% Jan 1, 2019 Dec 31, 2019
2018 -74 +1.27 +1.69% Jan 1, 2018 Dec 31, 2018
2017 -75.3 -15 -24.9% Jan 1, 2017 Dec 31, 2017
2016 -60.3 -13.4 -28.5% Jan 1, 2016 Dec 31, 2016
2015 -46.9 -6.08 -14.9% Jan 1, 2015 Dec 31, 2015
2014 -40.8 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.